Cargando…

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update

Neuropsychiatric symptoms affect most patients with dementia over the course of the disease. They include a wide variety of symptoms from apathy and depression to psychosis, irritability, impulsivity and agitation. These symptoms are associated with significant distress to the patient and caregivers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogowska, Marianna, Thornton, Mary, Creese, Byron, Velayudhan, Latha, Aarsland, Dag, Ballard, Clive, Tsamakis, Konstantinos, Stewart, Robert, Mueller, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747539/ https://www.ncbi.nlm.nih.gov/pubmed/36513918 http://dx.doi.org/10.1007/s40266-022-00992-5

Ejemplares similares

Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
por: Mueller, Christoph, et al.
Publicado: (2020)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023)

Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits
por: Stewart, Gavin R., et al.
Publicado: (2022)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

FLAME: A computerized neuropsychological composite for trials in early dementia
por: Brooker, Helen, et al.
Publicado: (2020)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings
por: McDermid, Joanne, et al.
Publicado: (2023)

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

The impact of the first UK COVID‐19 lockdown on presentations with psychosis to mental health services for older adults: An electronic health records study in South London
por: Simkin, Lauren, et al.
Publicado: (2022)

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011)

A data‐driven examination of apathy and depressive symptoms in dementia with independent replication
por: Vasconcelos Da Silva, Miguel, et al.
Publicado: (2023)

Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects
por: Malekizadeh, Yasaman, et al.
Publicado: (2020)

Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19
por: Owens, Andrew P., et al.
Publicado: (2020)

Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020
por: Creese, Byron, et al.
Publicado: (2020)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

A Preliminary Investigation of the Views of People With Parkinson's (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey
por: McGoohan, Katie, et al.
Publicado: (2020)

Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial
por: Meads, David M., et al.
Publicado: (2019)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Association of antipsychotic use with raised eosinophil count
por: Tsamakis, Konstantinos, et al.
Publicado: (2021)

Antipsychotics and dementia
por: Gareri, P, et al.
Publicado: (2010)

Clinical factors associated with progression to dementia in people with late-life depression: a cohort study of patients in secondary care
por: Peakman, Georgia, et al.
Publicado: (2020)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease
por: Handy, Alex, et al.
Publicado: (2021)

Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge
por: Cousins, Oliver, et al.
Publicado: (2023)

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia
por: Vallortigara, Julie, et al.
Publicado: (2014)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice
por: Zuidema, Sytse U., et al.
Publicado: (2015)

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias
por: Xing, Huayang, et al.
Publicado: (2016)

Potential Antipsychotic Side Effects and Adverse Events of Assisted Living Residents With Dementia
por: Beeber, Anna, et al.
Publicado: (2020)

Associated mortality risk of atypical antipsychotic medication in individuals with dementia
por: Phiri, Peter, et al.
Publicado: (2022)

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
por: Howlett, David R., et al.
Publicado: (2014)

Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pudrabraaftojtcm3kqcpl6jvq